ReviewFrontiers in oncology2026

ApoA2 isoforms as blood-based biomarkers reflecting pancreatic exocrine dysfunction for risk stratification and perioperative management of pancreatic cancer.

Akira Matsushita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.